Millipore Sigma Vibrant Logo

504041 CaCC Blocker IV, Benzbromarone - CAS 3562-84-3 - Calbiochem

CaCC Blocker IV, Benzbromarone - CAS 3562-84-3 - Calbiochem: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: (3,5-dibromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)methanone, ANO Blocker IV, Anoctamin Blocker IV, BBR, CaCC Blocker IV, Calcium-Activated Chloride Channel Blocker IV, TMEM16 Blocker IV

Primary Target: TMEM16A-CaCC
View This Product on Sigma-Aldrich
504041
価格＆在庫状況を照会

概要

Replacement Information

主要スペック表

CAS #Empirical Formula
3562-84-3C₁₇H₁₂Br₂O₃

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
5.04041.0001
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 ｶﾞﾗｽﾋﾞﾝ 100 mg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewA cell-permeable uricosuric agent that, in addition to its known efficacy in gout treatment, acts as a reversible CaCC blocker and is reported to be more potent than NFA (Cat. No. 481987) and NPPB (Cat. No. 484100) in suppressing 500 nM Ionomycin- (Cat. Nos. 407950, 407952, and 407953) induced I- influx in TMEM16A-expressing HEK293 cells (IC50 = 9.97, 140, and 150 µM, respectively) as well as in blocking voltage-gated Cl- current in TMEM16B-expressing HEK293 cells, while exhibiting much reduced potency against ENaC (α, β, and γ) or CFTR. Shown to significantly reduce mucin secretion from NHBE (normal human bronchial epithelial) and suppress human ASM (airway smooth muscle) contraction upon muscarinic receptor stimulation.
      Catalogue Number504041
      Brand Family Calbiochem®
      Synonyms(3,5-dibromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)methanone, ANO Blocker IV, Anoctamin Blocker IV, BBR, CaCC Blocker IV, Calcium-Activated Chloride Channel Blocker IV, TMEM16 Blocker IV
      References
      ReferencesKobayashi, K., et al. 2012. Drug Metab. Pharmacokinet. In press.
      Zhang, C.H., et al. 2013. Am. J. Respir. Crit. Care Med. 187, 374.
      Huang, F., et al. 2012. Proc. Natl. Acad. Sci. USA. 109, 16354.
      Fujimori, S., et al. 2011. Nucleosides Nucleotides Nucleic Acids 30, 1035.
      Perez-Ruiz, F., et al. 1998. Ann. Rheum. Dis. 57, 545.
      Product Information
      CAS number3562-84-3
      FormWhite powder
      Hill FormulaC₁₇H₁₂Br₂O₃
      Chemical formulaC₁₇H₁₂Br₂O₃
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetTMEM16A-CaCC
      Purity≥97% by HPLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      R PhraseR: 25

      Toxic if swallowed.
      S PhraseS: 45

      In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Toxic
      Hazardous Materials Attention: Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      5.04041.0001 04055977264234

      Documentation

      CaCC Blocker IV, Benzbromarone - CAS 3562-84-3 - Calbiochem (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      CaCC Blocker IV, Benzbromarone - CAS 3562-84-3 - Calbiochem 試験成績書（CoA）

      タイトルロット番号
      504041

      参考資料

      参考資料の概要
      Kobayashi, K., et al. 2012. Drug Metab. Pharmacokinet. In press.
      Zhang, C.H., et al. 2013. Am. J. Respir. Crit. Care Med. 187, 374.
      Huang, F., et al. 2012. Proc. Natl. Acad. Sci. USA. 109, 16354.
      Fujimori, S., et al. 2011. Nucleosides Nucleotides Nucleic Acids 30, 1035.
      Perez-Ruiz, F., et al. 1998. Ann. Rheum. Dis. 57, 545.
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision23-May-2013 JSW
      Synonyms(3,5-dibromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)methanone, ANO Blocker IV, Anoctamin Blocker IV, BBR, CaCC Blocker IV, Calcium-Activated Chloride Channel Blocker IV, TMEM16 Blocker IV
      DescriptionA cell-permeable uricosuric agent that, in addition to its known efficacy in gout treatment, acts as a reversible CaCC blocker and is reported to be more potent than NFA (Cat. No. 481987) and NPPB (Cat. No. 484100) in suppressing 500 nM Ionomycin- (Cat. Nos. 407950, 407952, and 407953) induced I- influx in TMEM16A-expressing HEK293 cells (IC50 = 9.97, 140, and 150 µM, respectively) as well as in blocking voltage-gated Cl- current in TMEM16B-expressing HEK293 (64% inhibition with 10 µM BBR vs. 47% inhibition with 300 µM NFA; by whole cell patch clamp), while exhibiting much reduced potency against voltage-gated current via ENaC (α, β, and γ) or CFTR (by 25% and 17% with 10 µM BBR, respectively, using HEK293 ENaC or CFTR transfectants). Shown to significantly reduce 100 µM ATP-induced CaCC current (IAC current = 1.137 vs. 3.099 µA/cm2 with or without 10 µM BBR) and mucin secretion from NHBE (normal human bronchial epithelial) as well as suppress human ASM (airway smooth muscle) contraction upon muscarinic receptor stimulation.
      FormWhite powder
      Intert gas (Yes/No) Packaged under inert gas
      CAS number3562-84-3
      Chemical formulaC₁₇H₁₂Br₂O₃
      Structure formulaStructure formula
      Purity≥97% by HPLC
      SolubilityDMSO (100 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Toxic
      ReferencesKobayashi, K., et al. 2012. Drug Metab. Pharmacokinet. In press.
      Zhang, C.H., et al. 2013. Am. J. Respir. Crit. Care Med. 187, 374.
      Huang, F., et al. 2012. Proc. Natl. Acad. Sci. USA. 109, 16354.
      Fujimori, S., et al. 2011. Nucleosides Nucleotides Nucleic Acids 30, 1035.
      Perez-Ruiz, F., et al. 1998. Ann. Rheum. Dis. 57, 545.